ABOUT CENCORA
Cencora combines core pharmaceutical distribution with innovative business solutions to help our partners across the healthcare spectrum get medications to the patients who need them. Biopharmaceutical companies benefit from the global scale and resources of a company ranked #10 on the Fortune 500, combined with local expertise provided by more than 51,000 team members worldwide. Learn more at www.cencora.com.
Whether you are developing and commercializing small molecules, biologics, or advanced therapies, Cencora can provide the deep scientific, regulatory, and technical expertise you need across the product life cycle. Our regulatory affairs, operations, and CMC services help improve the speed, quality, and consistency of manufacturing through submissions and beyond to reduce risk and optimize product launches.
VIDEOS AND WEBINARS
-
![GettyImages-2149321181 colleagues, meeting]( "Integrated Quality, Regulatory, And Safety Services")
Integrated Quality, Regulatory, And Safety ServicesA single-vendor model for quality, regulatory, and safety services provides consistent project management and cost-effective scalability. Hear how integrated solutions support market entry and growth.
-
![GettyImages-1204037710 meeting]( "Understanding PRCI And Its Requirements")
Understanding PRCI And Its RequirementsNavigating Health Canada's clinical information disclosure process takes real precision and preparation. Ensure your submission stays compliant, on schedule, and ready for review.
-
![Cencora - Orchestration]( "Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order Management")
Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order ManagementStreamline complex cell and gene therapy logistics with an integrated platform that connects manufacturers with vital services, providing full visibility and control for a more efficient and successful patient journey.
-
![Strategic Logistics]( "Crafting Scalable Solutions For Maximum Reach And Success")
Crafting Scalable Solutions For Maximum Reach And SuccessIs your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.
-
![Maximizing Impact]( "Maximizing Impact: Strategies For Building Robust Patient Support Programs")
Maximizing Impact: Strategies For Building Robust Patient Support ProgramsPanelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.
-
![Navigating Special Regulatory Pathways For Advanced Therapy Development Success]( "Navigating Special Regulatory Pathways For Advanced Therapy Development Success")
Navigating Special Regulatory Pathways For Advanced Therapy Development SuccessDon't let regulatory hurdles slow you down. Learn from leading experts about special designations like RMAT and PRIME to accelerate your advanced therapy development and ensure success.
CONTACT INFORMATION
Cencora
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
FEATURED INSIGHTS
-
![GettyImages-657049072 vaccine, pharma]( "Best Practices For Managing The Logistics And Distribution Of CGTs")
Site infrastructure, formulary timelines, and storage capabilities create barriers between approval and patient access. Planning for these operational realities separates successful launches from stalled ones.
-
![GettyImages-1248237924 IV]( "Navigating EU Regulatory Challenges With Cell And Gene Therapies")
EU regulatory changes affecting advanced therapies demand new approaches to scientific advice, evidence generation, and health technology assessment for cell and gene therapy developers.
-
![GettyImages-2167387228 meeting, strategy]( "The Value Of Real-World Evidence In Canadian Drug Commercialization")
Leveraging real-world evidence (RWE) across the product lifecycle enables manufacturers to fill the evidence gap beyond RCTs to help guide local commercial strategic planning and market access strategy.
-
![GettyImages-1367214441 business, meeting]( "Digitized Solutions To Increase Visibility And Streamline Communication Between A PSP And Manufacturer")
When email-based escalation management creates compliance and visibility gaps, a centralized digital solution helps manufacturer and PSP teams act faster and with greater accountability.
-
![GettyImages-2166459777 digital twins, technology]( "Digital Twins And Hybrid Models In Biologics Production: A Model Comparison")
Hybrid models outperform classical approaches in bioreactor prediction. See how combining mechanistic knowledge with machine learning builds process understanding that holds up beyond training conditions.
LEARN MORE ABOUT OUR SOLUTIONS
-
![GettyImages-891264822 planning, meeting]( "The Benefits Of Engaging In Pre-Approval Information Exchange (PIE)")
Explore the top 3 insights on the impact of pre-approval communication and learn why healthcare decision makers want more pre-approval resources and engagement from manufacturers.
WHITE PAPERS
-
![GettyImages-1137143869 world map]( "Unlock The Potential Of Pharmacovigilance Outsourcing")
Unlock The Potential Of Pharmacovigilance OutsourcingOutsourcing pharmacovigilance can reduce overhead, strengthen compliance, and free teams to focus on innovation. Examine what a well-structured global PV model actually looks like in practice.
